|
|
||||||||
Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts
Correspondence: For correspondence or reprints contact: Robert Licho, MD, Department of Radiology, University of Massachusetts Medical School, 55 Lake Ave. North, Worcester, MA 01655.
ABSTRACT
Brain SPECT imaging using 99mTc lipophilic tracers such as hexamethyl propyleneamine oxime (HMPAO) attempts to estimate cerebral, cerebellar and subcortical perfusion by assessing the relative amount of tracer uptake among these regions. Most commonly, comparison is made with cerebellar activity. Because the assessment of relative tracer uptake may be rendered inaccurate by photon attenuation by the nonuniform attenuation properties of the head, brain SPECT reconstructions have been compared using attenuation correction (AC) with various methods for estimating the attenuation map. Methods: Patients underwent 99mTc-HMPAO brain SPECT with transmission line source AC hardware. In addition to the emission dataset, emission downscatter and transmission datasets were acquired. Iterative reconstructions using three different attenuation maps were investigated. These included: (a) that obtained from transmission imaging, (b) that obtained from segmentation of a reconstruction from a lower energy Compton scatter window and (c) a slice-independent, uniform, elliptical attenuation map. No AC was also compared. Results: Count profiles in patients having brain perfusion SPECT scans showed a significant difference in region count estimates in the brain depending on whether AC is used as well as on the attenuation map used. Scatter-based AC is able to provide external contour detection and attenuation compensation based on that contour, whereas transmission-based AC provides external contour detection as well as internal, nonuniform attenuation estimation and AC. If one considers transmission AC to be the clinical "gold standard," non-attenuation-corrected as well as fixed-ellipsoid, uniform attenuation-corrected studies provided unreliable regional estimates of tracer activity. Conclusion: This study shows the significant difference in clinical brain SPECT count profiles depending on how and whether there is compensation for attenuation. Based on prior studies validating the improved quantitative accuracy of SPECT using transmission-based AC, this study suggests that clinical 99mTc brain perfusion SPECT would benefit from and, in situations demanding rigorous quantitative assessment, requires transmission-based AC. Estimating attenuation maps with scatter-based methods was the next most accurate (clinical) method tested and can be used if and when transmission imaging cannot be used.
Key Words: brain SPECT neuro-SPECT brain perfusion attenuation correction
This article has been cited by other articles:
![]() |
R. Accorsi Brain Single-Photon Emission CT Physics Principles AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1247 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. El Fakhri, M. F. Kijewski, M. S. Albert, K. A. Johnson, and S. C. Moore Quantitative SPECT Leads to Improved Performance in Discrimination Tasks Related to Prodromal Alzheimer's Disease J. Nucl. Med., December 1, 2004; 45(12): 2026 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kim, A. Varrone, H. Watabe, M. Shidahara, M. Fujita, R. B. Innis, and H. Iida Contribution of Scatter and Attenuation Compensation to SPECT Images of Nonuniformly Distributed Brain Activities J. Nucl. Med., April 1, 2003; 44(4): 512 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zaidi and B. Hasegawa Determination of the Attenuation Map in Emission Tomography J. Nucl. Med., February 1, 2003; 44(2): 291 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Van Laere, M. Koole, T. Kauppinen, M. Monsieurs, L. Bouwens, and R. Dierck Nonuniform Transmission in Brain SPECT Using 201Tl, 153Gd, and 99mTc Static Line Sources: Anthropomorphic Dosimetry Studies and Influence on Brain Quantification J. Nucl. Med., December 1, 2000; 41(12): 2051 - 2062. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |